Adobe Flex Authors: Matthew Lobas, PR.com Newswire, Shelly Palmer, Kevin Benedict

News Feed Item

Intralinks Survey: Life Sciences Deal Activity Will Increase in 2010

More Than Half of Industry Executives Anticipate Multiple Deals Next Year

NEW YORK, NY -- (Marketwire) -- 11/18/09 --

IntraLinks/BioNetwork West 2009 Facts:

-- IntraLinks®, the leading provider of critical information exchange solutions, today announced the results of a survey of key decision makers attending the BioNetwork West 2009 conference on their anticipated deal activity in 2010 and the ways they expect to conduct them.

-- IntraLinks' Alison Shurell, VP of Product Marketing, spoke on the conference's keynote panel, "Adopting Best Practices to Expedite Due Diligence," with Kevin Kuehm, VP Global Transactions and BD&L for Bayer Healthcare, Anne Dollard, Deputy General Counsel and Chief Patent Counsel for Takeda San Francisco and Jim Hattersley, VP Business Development at Sun Pharmaceutical Industries.

-- For the past ten years, IntraLinks virtual datarooms have expedited the due diligence activity of hundreds of licensing, financing and M&A deals for pharmaceutical, biotech and medical devices companies. In addition to supporting business development & licensing activity, IntraLinks also allows sponsors and CROs to better manage, track and exchange regulatory documents with investigators during clinical trials through IntraLinks' secure, online platform.

Survey Facts:

-- Key survey findings:

- 92 percent of survey respondents indicated they expect to see some level of deal activity in the next 12 months. Of that group, 57 percent of survey respondents indicated they expect to do 1-4 deals.

- More than half of survey respondents indicated that 50-100 percent of their deals are done using a virtual dataroom (VDR).

- 96 percent of survey respondents indicated that some portion of their deals include large, linked documents such as Investigational New Drug Applications (INDs), Non-disclosure Agreements (NDAs), among others. Of that group, 33 percent indicated that this is the case in the majority (76-100 percent) of their deals.

-- Survey participants included top decision makers and executives from major life sciences and pharmaceutical companies including: Bayer, Eli Lilly (LLY), GlaxoSmithKline (GSK), Madeira, Merck (MRK), New Link Genetics, Novartis (NVS), Proctor & Gamble (PG), Sanofi-Aventis, Shire Pharmaceuticals (SHPGY), and Watson Pharma (WPI).

Supporting Quotes:

-- "The conference facilitated networking between members of the Life Sciences community -- from biotechs to big pharma and everyone in between," said Alison Shurell, VP of Product Marketing for IntraLinks. "The atmosphere was friendly -- people were there because they wanted to connect with others to discuss promising compounds, technology and pipelines and explore possible partnerships."

-- "The overall results of this survey reflect a trend we are seeing in the Life Sciences industry of companies looking to move their critical information to a secure online environment that is controlled and compliant, like IntraLinks' solution," said Alison Shurell, VP of Product Marketing for IntraLinks. "Physical due diligence is truly becoming a thing of the past."

-- "Life sciences deals such as licensing deals include large, linked documents; more than a third of survey respondents indicated this is true for the majority (76-100 percent) of their deals," said Alison Shurell, VP of Product Marketing for IntraLinks. "This affirms what we've been hearing from clients, and underlines the need for a solution that can maintain the integrity of the links in documents such as INDs, NDAs and other regulatory documents when you move the process online. IntraLinks is the only solution on the market with this capability, allowing potential partners to conduct all of their due diligence activity in a secure, online environment."

Supporting Resources/Related Links:

-- Alison Shurell's Presentation via IntraLinks' Blog: http://blog.intralinks.com/blog/2009/10/15/bionetwork-2009-keynote-panel-adopting-best-practices-expedite-due-diligence-process

-- BioNetwork West 2009 Presentations: http://www.wbresearch.com/bionetworkwest/Presentations.aspx

-- Company Announcements:

- IntraLinks Accelerates Drug Funding in the Pipeline for Fast Forward (August 27, 2009)

- IntraLinks Announces Partnership with Adobe Systems Inc. to develop New Tool for Life Sciences Data Capture and Submission-Based Business (November 4, 2009)

-- Company Demo: Life Sciences

-- Whitepaper: Clinical Document Exchange Portals: "Faster Study Start-up and Reduced Costs Through the use of Clinical Document Exchange Portals"

About IntraLinks

IntraLinks provides on-demand solutions for businesses to securely collaborate, communicate and exchange critical information inside and outside the enterprise. For more than a decade, 750,000 professionals from more than 90,000 organizations have relied on IntraLinks to accelerate workflow, optimize business processes and realize new profit potential. IntraLinks counts 800 of the Fortune 1000 as clients, including AstraZeneca Pharmaceuticals LP, Bank of America, Deutsche Bank and the FDIC. For more information, please visit www.intralinks.com, http://blog.intralinks.com/, or http://twitter.com/intralinks.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Alison Koski
[email protected]

Isa Loundon
[email protected]

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

IoT & Smart Cities Stories
Whenever a new technology hits the high points of hype, everyone starts talking about it like it will solve all their business problems. Blockchain is one of those technologies. According to Gartner's latest report on the hype cycle of emerging technologies, blockchain has just passed the peak of their hype cycle curve. If you read the news articles about it, one would think it has taken over the technology world. No disruptive technology is without its challenges and potential impediments t...
Nicolas Fierro is CEO of MIMIR Blockchain Solutions. He is a programmer, technologist, and operations dev who has worked with Ethereum and blockchain since 2014. His knowledge in blockchain dates to when he performed dev ops services to the Ethereum Foundation as one the privileged few developers to work with the original core team in Switzerland.
Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settlement products to hedge funds and investment banks. After, he co-founded a revenue cycle management company where he learned about Bitcoin and eventually Ethereal. Andrew's role at ConsenSys Enterprise is a mul...
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
If a machine can invent, does this mean the end of the patent system as we know it? The patent system, both in the US and Europe, allows companies to protect their inventions and helps foster innovation. However, Artificial Intelligence (AI) could be set to disrupt the patent system as we know it. This talk will examine how AI may change the patent landscape in the years to come. Furthermore, ways in which companies can best protect their AI related inventions will be examined from both a US and...
In his general session at 19th Cloud Expo, Manish Dixit, VP of Product and Engineering at Dice, discussed how Dice leverages data insights and tools to help both tech professionals and recruiters better understand how skills relate to each other and which skills are in high demand using interactive visualizations and salary indicator tools to maximize earning potential. Manish Dixit is VP of Product and Engineering at Dice. As the leader of the Product, Engineering and Data Sciences team at D...
Bill Schmarzo, Tech Chair of "Big Data | Analytics" of upcoming CloudEXPO | DXWorldEXPO New York (November 12-13, 2018, New York City) today announced the outline and schedule of the track. "The track has been designed in experience/degree order," said Schmarzo. "So, that folks who attend the entire track can leave the conference with some of the skills necessary to get their work done when they get back to their offices. It actually ties back to some work that I'm doing at the University of San...
When talking IoT we often focus on the devices, the sensors, the hardware itself. The new smart appliances, the new smart or self-driving cars (which are amalgamations of many ‘things'). When we are looking at the world of IoT, we should take a step back, look at the big picture. What value are these devices providing. IoT is not about the devices, its about the data consumed and generated. The devices are tools, mechanisms, conduits. This paper discusses the considerations when dealing with the...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...
Dynatrace is an application performance management software company with products for the information technology departments and digital business owners of medium and large businesses. Building the Future of Monitoring with Artificial Intelligence. Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more busine...